Chongqing Pharscin Pharmaceutical Co., Ltd. (SHE:002907)

China flag China · Delayed Price · Currency is CNY
11.96
+0.08 (0.67%)
Jun 10, 2026, 3:04 PM CST
Market Cap4.99B -12.8%
Revenue (ttm)800.05M +1.9%
Net Income57.52M -25.0%
EPS0.14 -25.0%
Shares Out 417.60M
PE Ratio86.80
Forward PEn/a
Dividend0.08 (0.63%)
Ex-Dividend DateJun 4, 2026
Volume2,395,898
Open11.80
Previous Close11.88
Day's Range11.68 - 12.07
52-Week Range11.68 - 21.52
Beta-0.16
Analystsn/a
Price Targetn/a
Earnings DateAug 21, 2026

About SHE:002907

Chongqing Pharscin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of drugs in China. The company offers tablets, powders, granules, soft capsules, powder injections, freeze-dried powders, injections, chemical raw materials, and small volume injections. It provides its products for the treatment of CNS, digestion, otolaryngology, oncology, cardiovascular, and cerebrovascular related diseases. Chongqing Pharscin Pharmaceutical Co., Ltd. was founded in 1996 and is headquartered in Chongqing, China. [Read more]

Sector Healthcare
Founded 1996
Employees 1,439
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002907
Full Company Profile

Financial Performance

In 2025, SHE:002907's revenue was 827.14 million, an increase of 6.75% compared to the previous year's 774.82 million. Earnings were 65.09 million, a decrease of -15.17%.

Financial Statements